Systematic assessment of mixed imputation methods and explainable machine learning

Abstract

The convergence of artificial intelligence and precision oncology is frequently hampered by the quality of real-world clinical data, particularly the pervasive challenge of missing values. This opinion review critically appraises the methodology and evidentiary framework of the study, which proposes a hybrid imputation architecture, HDI-MF-Gower, integrated with an extra trees classifier and Shaply Additive exPlanation interpretability for predicting survival outcomes following curative gastrectomy. We deconstruct the pivotal assumptions and potential sensitivities of their adaptive weighted similarity initialization. This design is engineered to provide a “warm start” aligned with the underlying data structure for iterative imputation, theoretically mitigating the risks of distributional distortion associated with simplistic initialization strategies. However, a primary boundary of the current evidence lies in the validation hierarchy; the reported validation relies predominantly on random splitting within a single-center cohort, lacking the robustness of temporal extrapolation or genuine external validation. Furthermore, statistical comparisons suggest that the performance differences between the proposed model and several robust ensemble baselines are not consistently distinguishable, making it difficult to attribute performance gains solely to the specific choice of the learner. We conclude that future research must construct a more rigorous evidence chain within multicenter and multimodal frameworks. Crucially, adherence to transparent reporting of a multivariable prediction model for individual prognosis or diagnosis + artificial intelligence guidelines - specifically regarding missing data mechanisms, sensitivity analyses, calibration and net benefit assessments, and the availability of reproducible materials - is essential to substantiate generalizable clinical utility.